Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Cellectar Biosciences Says Its Cash Balance Of $25.9M As Of June 30, 2024, When Combined With The $19.4M Raised In July, Is Adequate To Fund Its Basic Budgeted Operations Into The Second Quarter Of 2025

Author: Benzinga Newsdesk | August 13, 2024 06:42am

Posted In: CLRB